53538-13-9 Usage
Uses
Used in Pharmaceutical Applications:
Apigenin 7-O-methylglucuronide is used as a therapeutic agent for its potential role in preventing and treating various health conditions. Its antioxidant and anti-inflammatory properties contribute to its potential benefits in managing these conditions.
Used in Cancer Treatment:
Apigenin 7-O-methylglucuronide is used as an anti-cancer agent for its ability to inhibit tumor growth and promote apoptosis in cancer cells. It has demonstrated potential in the prevention and treatment of various types of cancer.
Used in Cardiovascular Disease Prevention:
Apigenin 7-O-methylglucuronide is used as a preventive agent for cardiovascular diseases due to its potential to reduce inflammation and oxidative stress, which are key factors in the development of these conditions.
Used in Neurodegenerative Disorder Management:
Apigenin 7-O-methylglucuronide is used as a therapeutic agent for neurodegenerative disorders, such as Alzheimer's and Parkinson's diseases, due to its potential neuroprotective effects and ability to reduce inflammation and oxidative stress in the brain.
Overall, Apigenin 7-O-methylglucuronide has demonstrated promising health benefits and is the subject of ongoing research for its potential therapeutic uses in various industries, including pharmaceuticals, healthcare, and nutraceuticals.
Check Digit Verification of cas no
The CAS Registry Mumber 53538-13-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,3,5,3 and 8 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 53538-13:
(7*5)+(6*3)+(5*5)+(4*3)+(3*8)+(2*1)+(1*3)=119
119 % 10 = 9
So 53538-13-9 is a valid CAS Registry Number.
53538-13-9Relevant academic research and scientific papers
A 5, 4' - dihydroxy flavone - 7 - O - D - glucuronic acid preparation method
-
, (2018/03/26)
The invention relates to the drug synthesis technical field, and in particular, relates to a preparation method of 5,4'-dihydroxy flavone-7-O-D-glucuronic acid. The method comprises the following steps: taking a compound having a structure represented by the formula II, and under an alkaline condition, acylating to obtain a compound having a structure represented by the formula III; taking the compound having the structure represented by the formula III and alpha-bromo triacetoxy methyl glucuronate, and carrying out a glycosylation reaction, to obtain a compound having a structure represented by the formula IV; taking the compound having the structure represented by the formula IV, and hydrolyzing under an acidic condition, to obtain a compound having a structure represented by the formula V; and taking the compound having the structure represented by the formula V, hydrolyzing under an alkaline condition, and thus obtaining the product. The method provided by the invention has the advantages of cheap and easily obtained starting raw materials, less reaction steps, and simple and easily operated process, and is suitable for large-scale industrialized production; and through testing, the purity of the obtained product can reach more than 98%, and the total yield reaches up to 56%.
